India Organ-On-Chip Market Research Report By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) - Forecast to 2035

India Organ-On-Chip Market Overview

As per MRFR analysis, the India Organ-On-Chip Market Size was estimated at 2.69 (USD Million) in 2023.The India Organ-On-Chip Market Industry is expected to grow from 4.02(USD Million) in 2024 to 17.42 (USD Million) by 2035. The India Organ-On-Chip Market CAGR (growth rate) is expected to be around 14.26% during the forecast period (2025 - 2035).

Key India Organ-On-Chip Market Trends Highlighted

The India Organ-On-Chip market is witnessing remarkable trends because of the developments in biotechnology and the regulatory environment. The government of India is encouraging R&D in biomedicine through “Make in India” initiatives, which promotes manufacturing and innovation within the country. This has triggered universities and research centers to focus on organ-on-chip technologies aimed at drug development and disease modeling ness to the healthcare demands of the country. In addition, there is increased intercommunication between academic and industrial professionals, which is beneficial for fostering innovation. There is great potential to be pursued in the region, especially regarding tailored therapies and minimizing the use of animals in research.

Organ-on-chip technology is positioned as a potential solution for Indian pharmaceutical companies that are searching for alternatives to conventional methods of testing. The prevalence of chronic diseases in India is rising and with it the demand for efficient drug testing methods to shorten time-to-market. There is also a notable increase in investment and partnership activity for biotechnology emerging with new sector start-ups. Furthermore, the growing awareness of organ-on-chip technology among researchers and clinicians is accelerating its adoption in drug discovery and toxicology studies. Focused on becoming a global biotechnology hub, India is strategically moving towards the use of organ-on-chip technology which has the potential to transform the country’s healthcare system.

India Organ-On-Chip Market Drivers

Rising Demand for Personalized Medicine

The increasing pursuit of personalized medicine in India is one of the significant drivers for the growth of the India Organ-On-Chip Market Industry. The Indian government has been actively promoting policy changes aimed at enhancing the healthcare system, with a focus on individualized treatment approaches. Personalized medicine reduces the trial-and-error approach in drug development, thus streamlining the market. 

A recent report from the Indian Council of Medical Research indicates that the prevalence of chronic diseases, such as cardiovascular diseases and diabetes, has surged by approximately 26% over the last decade, advocating the need for tailored therapeutic strategies.Organizations like the All India Institute of Medical Sciences are championing research projects that leverage organ-on-chip technology to analyze drug responses in a patient-specific manner, thereby driving the demand within the organ-on-chip segment.

Technological Advancements in Biomedical Engineering

The rapid technological advancements in the field of biomedical engineering are propelling the India Organ-On-Chip Market Industry forward. Innovations in microfabrication techniques and cell culture technologies have made organ-on-chip systems more reliable and accessible for research. The Department of Biotechnology, under the Ministry of Science and Technology in India, has funded numerous initiatives that enhance the development of modular organ-on-chip devices.Statistically, research published in various scientific journals suggests that these advancements could improve drug testing efficiency by up to 40% compared to traditional methods, thus amplifying the market prospects.

Regulatory Support for Innovative Health Solutions

The regulatory environment in India has become increasingly supportive of innovative health solutions, which serves as a catalyst for the India Organ-On-Chip Market Industry. The Drug Controller General of India has expedited the approval processes for advanced therapeutic technologies, including organ-on-chip models, thus stimulating market growth. In line with the National Health Policy, which aims to promote innovation in medical practices and minimize the time for getting products to market, this supportive regulatory framework aligns with global health trends.Approximately 30% of newly approved medical devices in the last few years have incorporated novel technologies that include organ models for drug evaluation, thus indicating the efficacy and future potential of the organ-on-chip segment.

India Organ-On-Chip Market Segment Insights

Organ-On-Chip Market Organ Type Insights

The Organ Type segment of the India Organ-On-Chip Market is rapidly evolving, reflecting a significant shift in biomedical research and drug testing methodologies. The segment includes diverse and innovative constructs such as Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, and Human-on-Chip systems. Each of these constructs serves a vital function in mimicking human physiological responses, providing researchers with more accurate models to study diseases and test therapeutics compared to traditional methods. 

For instance, Lung-on-Chip technology is particularly important as it replicates the intricacies of human lungs, allowing for deep insights into respiratory diseases and the effects of various pharmaceuticals on lung tissues. Similarly, the Heart-on-Chip model is essential for cardiovascular research, as it enables the observation of heart rate, rhythm, and the effects of drugs on cardiac tissues in a controlled environment, thereby minimizing the reliance on animal testing.India's focus on advancing healthcare through innovative technologies has positioned the Organ-On-Chip segment at the forefront of research and development initiatives. 

The Liver-on-Chip systems contribute significantly to toxicology testing, offering a more precise understanding of metabolism and toxicity that aligns closely with human responses, which is a critical factor for the pharmaceutical industry in the country. Individuals researching gastrointestinal disorders benefit from the Intestine-on-Chip, as it aids in studying digestive processes and drug delivery efficacy. 

Furthermore, the Kidney-on-Chip unit plays a significant role in nephrology, providing insights into renal functions and drug effects, potentially revolutionizing treatments for kidney diseases. Last but not least, the Human-on-Chip platform functions as a holistic bioengineering approach that integrates multiple organ systems, allowing for comprehensive studies on systemic effects of diseases and interventions.The collaboration between Indian research institutions and government initiatives is expected to further enhance the development of the Organ Type segment, fostering an environment that encourages innovation. 

The rising investment in Research and Development and the increasing adoption of personalized medicine approaches are driving the demand for Organ-on-Chip technologies in India. As regulatory agencies start recognizing the potential of these advanced systems, the industry is likely to witness substantial growth opportunities. Thus, the Organ Type segment signifies a pivotal aspect of the India Organ-On-Chip Market, contributing to the transformation of personalized healthcare solutions, disease modeling, and drug discovery while addressing critical health challenges faced by the Indian population.

Organ-On-Chip Market Application Insights

The Application segment of the India Organ-On-Chip Market showcases considerable growth potential driven by the increasing need for innovative solutions in biomedical research. Drug Discovery has emerged as a critical area within this segment, as it enables researchers to predict drug responses more accurately, thereby improving the efficiency of the drug development process and minimizing risks associated with traditional testing methods. Toxicology Research is also gaining prominence, being essential for understanding the safety profiles of new compounds and streamlining regulatory compliance.

This application not only improves safety but also reduces costs and time spent on animal testing. Overall, the Applications segment illustrates a shift towards more ethical and efficient research methodologies in India, aligning with governmental initiatives aimed at promoting advanced biotechnologies. As the demand for personalized medicine and targeted therapeutics grows, the relevance of these applications in enhancing drug efficacy and safety becomes undeniable, impacting both the pharmaceutical landscape and public health outcomes significantly.The integration of organ-on-chip technologies progresses towards more sophisticated models that replicate human physiology, thereby setting the stage for transformative advancements in the India Organ-On-Chip Market.

Organ-On-Chip Market End-User Insights

The End-User segment of the India Organ-On-Chip Market showcases significant potential driven largely by Pharmaceutical Companies and Research Organizations, among others. Pharmaceutical Companies are increasingly integrating Organ-On-Chip technologies into their drug discovery processes, enhancing the efficiency of preclinical testing while reducing reliance on animal models. This shift is essential in a country like India, where the pharmaceutical industry continues to grow rapidly, positioning itself as a global hub for drug development and innovation.

Research Organizations also play a crucial role, focusing on advancing fundamental scientific research and developing new methodologies relevant to human disease modeling. Their collaboration with academic institutions encourages a continuous flow of innovative ideas and applications, which strengthens the overall ecosystem of organ-on-chip technology. The increasing demand for effective and ethical testing methods is further creating opportunities for other end-users as well, including educational institutions and government laboratories, that are striving to incorporate modern technologies into their curriculum and research projects.The landscape of this market segment is expected to evolve, reflecting the ongoing advancements and investments in biotechnology, making India a significant player in the global Organ-On-Chip landscape.

India Organ-On-Chip Market Key Players and Competitive Insights

The India Organ-On-Chip Market is an emerging sector that blends advanced biotechnology with cutting-edge engineering to create microfluidic devices that simulate human organ systems. This innovative technology is poised to revolutionize drug development, testing, and personalized medicine by providing a more accurate and ethical alternative to traditional animal testing. As research institutions and biotechnology firms increasingly seek to enhance their product development pipelines, the competitive landscape of this market is rapidly evolving. 

The participants in this sector are focusing on collaborations, research partnerships, and technological innovations to capture market share and drive growth. Regulatory support and rising funding from private and public sectors are also playing crucial roles in shaping the competitive dynamics, positioning India as a key player in the global Organ-On-Chip landscape.GRAIL holds a significant position in the India Organ-On-Chip Market, leveraging its extensive expertise in biomarker discovery and liquid biopsy technology. 

The company's strengths lie in its focus on early cancer detection and its innovative approach to bioengineering, which integrates organ-on-chip technology into its research processes. GRAIL has established a robust market presence in India by collaborating with leading research institutions and academic organizations, enabling it to enhance its product offerings and strengthen its research capabilities. 

The company's dedication to addressing critical healthcare challenges through technological advancements further solidifies its competitive edge in the Indian market, as it continues to work towards expanding its influence and penetration in the evolving landscape of personalized healthcare solutions.Kokiri Technology has made noteworthy strides within the India Organ-On-Chip Market by developing highly specialized platforms designed for drug testing and disease modeling. The company focuses on creating organ-on-chip systems that mimic specific human organ functions to better predict human responses to pharmaceutical compounds. Kokiri Technology's strengths include its advanced technological capabilities, which allow for real-time monitoring and assessment of biological responses, making it a valuable player in the biomedical field. 

The firm actively seeks to expand its market presence through strategic partnerships and collaborations with biopharmaceutical companies, research institutions, and healthcare providers in India. Its ability to adapt to market needs and a robust pipeline of innovative products position Kokiri Technology prominently within the industry. Additionally, the company's focus on research and development ensures that it remains competitive, while any potential mergers or acquisitions could further enhance its capabilities and market reach in India, tapping into the growing demand for more efficient and reliable testing methods in drug development.

Key Companies in the India Organ-On-Chip Market Include

• GRAIL


• Kokiri Technology


• Reliance Life Sciences


• Thermo Fisher Scientific


• Agarwal Eye Hospital


• MediSage


• MediTech


• Scripps Research


• AIBS


• Sankara Nethralaya


• Bharat Biotech


• Biocon


• Haplogen


• Context Therapeutics

India Organ-On-Chip Market Industry Developments

The India Organ-On-Chip Market has been witnessing significant developments recently. Companies like Thermo Fisher Scientific and Reliance Life Sciences are investing heavily in Research and Development to enhance their capabilities in bioengineering. In October 2023, GRAIL announced an expansion of its operations in India, aiming to leverage local expertise in organ-on-chip technology. 

Meanwhile, Kokiri Technology has partnered with Indian research institutions to promote the use of organ-on-chip systems in drug testing. In the mergers and acquisitions space, Biocon is rumored to be in discussions for a potential collaboration with Bharat Biotech to enhance their drug discovery platforms, which would significantly impact the market if finalized. 

Major happenings over the past two to three years include the establishment of new research collaborations between Agarwal Eye Hospital and Scripps Research in March 2022, focusing on innovative therapies using organ-on-chip models. Overall, the market is projected to grow as more companies recognize the potential of organ-on-chip technology, aligning with the Indian government's initiatives to boost biotechnology innovations and enhance healthcare outcomes in the country.

India Organ-On-Chip Market Segmentation Insights

Organ-On-Chip Market Organ Type Outlook

• Lung-on-Chip


• Heart-on-Chip


• Liver-on-Chip


• Intestine-on-Chip


• Kidney-on-Chip


• Human-on-Chip

Organ-On-Chip Market Application Outlook

• Drug Discovery


• Toxicology Research


• Others

Organ-On-Chip Market End-User Outlook

• Pharmaceutical Companies


• Research Organizations


• Others

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	2.69(USD Million)
MARKET SIZE 2024	4.02(USD Million)
MARKET SIZE 2035	17.42(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	14.26% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	GRAIL, Kokiri Technology, Reliance Life Sciences, Thermo Fisher Scientific, Agarwal Eye Hospital, MediSage, MediTech, Scripps Research, AIBS, Sankara Nethralaya, Bharat Biotech, Biocon, Haplogen, Context Therapeutics
SEGMENTS COVERED	Organ Type, Application, End-User
KEY MARKET OPPORTUNITIES	Research and development in pharmaceuticals, Personalized medicine applications, Toxicity testing advancements, Collaboration with biotech firms, Government funding initiatives
KEY MARKET DYNAMICS	increased investment in biotechnology, growing demand for personalized medicine, rising prevalence of chronic diseases, advancements in microfluidics technology, supportive government regulations
COUNTRIES COVERED	India